IC
DVAX

Innealta Capital’s Dynavax Technologies DVAX Stock Holding History

Innealta Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-72
Closed -$809 – 598
2024
Q2 		$809 Buy
+72
New +$838 ﹤0.01% 1361

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Innealta Capital's DVAX Position: Q3 2024 in Review

Innealta Capital sold out of Dynavax Technologies (DVAX) in Q3 2024, closing a stake of 72 shares — an estimated $809 sold.

Innealta Capital first reported a position in DVAX in Q2 2024 and held it in 1 quarter. The position peaked at $809 in Q2 2024. 251 funds tracked by Wall St. Rank hold DVAX as of Q3 2024.

  • Innealta Capital reported no remaining Dynavax Technologies position as of Q3 2024 after selling out during the quarter.
  • Innealta Capital sold 72 Dynavax Technologies shares in Q3 2024, an estimated $809.
  • Innealta Capital first reported a position in Dynavax Technologies in Q2 2024 and held it in 1 quarter.
  • Innealta Capital's Dynavax Technologies position peaked at $809 in Q2 2024.
  • 251 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.